NEW YORK (Reuters Health) May 27 –
Immunoabsorption therapy immediate prior to kidney transplantation can improve graft survival in patients with anti-human leukocyte antigen (HLA) antibodies, according to a report published in the April issue of Clinical Transplantation.
Previous renal transplantation, blood transfusions, and pregnancy can induce anti-HLA antibodies, which are known to increase the risk of hyperacute rejection during subsequent transplantation. Protein A immunoabsorption (IA) is one method of reducing the levels of these antibodies.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!